alternatives to glp-1 agonists Costs Explained: Managing Coverage Challenges alternative to glp 1 Possible
Description
Usdin TB, Mezey E, Button DC, et al

Continued Treatment with Tirzepatide for Maintenance of Weight Reduction in Adults with Obesity: the SURMOUNT-4 Randomized Clinical Trial
They confirmed that, compared with placebo, the DPP-4 inhibitors reduced HbA 1c by around 0.7%

Clinically, it is characterized by an excess accumulation of adipose tissue within the body, and it is formally defined as a body mass index (BMI) of 30 kg/m 2

113 Early diagnosis and targeted treatment strategies, including glycaemic optimisation, management of diarrhoea and constipation, review of medications and pelvic floor and sphincter training, are key for improving both symptom burden and overall quality of life

The participants were followed for a total of six months
